Evidence map›Paper›PMID 39351113›Full record

ArticleFrontiers in psychology2024

The impact of negative COVID-19 experiences on cancer survivors' health-related quality of life and psychological distress: a moderated mediation model.

Blanca S Noriega Esquives, Akina Natori, Michael H Antoni, Amy K Otto, Sarah Prinsloo, Richard W Wagner, Telma I Gomez, Cassandra A Hathaway, Cornelia M Ulrich, Anita R Peoples and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Blanca S Noriega Esquives *Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States.
Akina Natori *Division of Medical Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States.
Michael H AntoniSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States.
Amy K OttoUniversity of Minnesota Medical School, Duluth, MN, United States.
Sarah PrinslooDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.
Richard W WagnerDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.
Telma I GomezDepartment of Pediatrics Hematology-Oncology, Baylor College of Medicine, Houston, TX, United States.
Cassandra A HathawayWestat, Rockville, MD, United States.
Cornelia M UlrichHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Anita R PeoplesHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Lorenzo CohenDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.
Frank J PenedoSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States.

Funding

TRANSLATIONAL AND ANALYTICAL CHEMISTRY COREP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PETER W PISTERS · 1985 to 2026
$279.3M
Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Training to Reduce Burden across the Cancer Control Continuum (TRACC)T32CA251064 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI ERIN N KOBETZ, Frank J Penedo · 2020 to 2026
$3.2M
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA240139NCI NIH HHS T32 CA251064
6 · The paper itself

Abstract

Introduction: Cancer survivors experienced poorer health-related quality of life (HRQoL) and greater psychological distress during the COVID-19 pandemic than those without cancer. However, the underlying mechanisms that may explain how negative experiences during the pandemic are associated with distress and HRQoL remain unknown. We examined whether psychosocial risk factors (i.e., healthcare disruption, disruption to daily activities and social interaction [DDASI], and financial hardship) mediated the relationship between negative COVID-19-related experiences and cancer survivors' HRQoL and psychological distress (i.e., depressive symptoms, and anxiety) and whether the mediating effects were moderated by psychosocial protective factors (i.e., stress management ability and social support). Methods: A total of 9,651 cancer survivors completed a questionnaire assessing negative COVID-19-related experiences, psychosocial and practical experiences, and HRQoL. Conditional process analysis was used to evaluate the proposed moderated mediation models. Results: Participants had a mean age of 63.8 years (SD = 12.3) and were mostly non-Hispanic White (82.3%). DDASI and financial hardship mediated the relationship between negative COVID-19-related experiences and cancer survivor's HRQoL and psychological distress. Stress management ability buffered the indirect effect of DDASI on cancer survivors' HRQoL and psychological distress. Social support buffered the indirect effect of financial hardship on HRQoL and depressive symptoms. Conclusion: Financial resources and social interactions may buffer negative effects of major disruptions such as the COVID-19 pandemic. Future studies should assess the longitudinal impact of these associations.

Indexed as

cancer survivorsCOVID-19 pandemicfinancial hardshiphealth-related quality of lifemoderated mediation analysispsychological distress

Identifiers

PMID39351113
PMCPMC11440988

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.